Stockholders Equity (Details Narrative) - USD ($)				1 Months Ended	12 Months Ended
	Aug. 11, 2022	Aug. 09, 2022	Aug. 08, 2022	Nov. 25, 2020	Dec. 31, 2022	Dec. 31, 2021	Dec. 30, 2021	Apr. 15, 2021
Convertible debt					$ 145,066
Warrant conversion				30,174	39,000
Number of units, issued		780,000	117,000
Offering cost					$ 1,500,000
Aggregate net proceeds					1,800,000
Fair value of blacksholes of warrants	$ 107,164				$ 5,900,000
Conversion Price Per Shares		$ 4.25	$ 0.01		$ 4.675	$ 3.75
Exercise price		$ 4.25		$ 3.98				$ 3
Warrant expiry date				November 24, 2025
Preferred stock					0	0	10,000,000
Converted common stock, shares					9,073,137
Common Stock
Accrued interest					$ 42,959
Discription	underwriters, as a portion of the underwriting compensation payable to the Representative, warrants to purchase up to a total of 39,000 shares of Common Stock (the “Representative’s Warrants”)				underwritten public offering (“Offering”) was declared effective on August 8, 2022, and the Company’s common stock and warrants began trading on the Nasdaq Capital Market (“Nasdaq”) on August 9,2022 under the trading symbols “AIMD” and “AIMDW”, respectively. The Company completed its underwritten public offering of an aggregated 780,000 units at a public offering price of $4.25 per unit. Each unit issued in the offering consisted of one share of common stock and one warrant to purchase one share of common stock at an exercise price of $4.25. The foregoing described warrants may be exercised from February 5, 2023 (181 days from the effective date of our S-1 Registration Statement made effective August 8, 2022, hereafter “Registration Date”) to August 8, 2027 (5 years from the Registration Date)	underwriters a 45-day option to purchase up to an additional 117,000 shares of common stock and/or up to an additional 117,000 warrants at the public offering price to cover over-allotments. The underwriters partially exercised its option to purchase an additional 117,000 warrants
Principal amount					$ 30,400,000
Exercise price	$ 4.68